MORRONE, DORALISA
 Distribuzione geografica
Continente #
NA - Nord America 5.394
AS - Asia 2.757
EU - Europa 2.053
SA - Sud America 420
AF - Africa 138
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.775
Nazione #
US - Stati Uniti d'America 5.272
SG - Singapore 963
CN - Cina 688
IT - Italia 643
HK - Hong Kong 487
SE - Svezia 393
BR - Brasile 347
DE - Germania 296
VN - Vietnam 259
BG - Bulgaria 155
FI - Finlandia 115
FR - Francia 110
RU - Federazione Russa 96
GB - Regno Unito 93
CA - Canada 79
TR - Turchia 75
IN - India 48
CI - Costa d'Avorio 46
JP - Giappone 45
AT - Austria 35
BD - Bangladesh 33
AR - Argentina 31
IQ - Iraq 26
MX - Messico 23
NG - Nigeria 22
KR - Corea 19
ZA - Sudafrica 19
ID - Indonesia 18
UA - Ucraina 15
EC - Ecuador 13
PL - Polonia 13
SA - Arabia Saudita 12
SN - Senegal 12
CH - Svizzera 11
CO - Colombia 11
MA - Marocco 11
BE - Belgio 10
CZ - Repubblica Ceca 10
PK - Pakistan 10
ES - Italia 9
NL - Olanda 9
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
DZ - Algeria 7
PH - Filippine 7
EG - Egitto 6
GR - Grecia 6
KZ - Kazakistan 6
PE - Perù 6
UZ - Uzbekistan 6
AU - Australia 5
BY - Bielorussia 5
IE - Irlanda 5
TW - Taiwan 5
BH - Bahrain 4
HN - Honduras 4
HU - Ungheria 4
JO - Giordania 4
MY - Malesia 4
NZ - Nuova Zelanda 4
SY - Repubblica araba siriana 4
VE - Venezuela 4
CL - Cile 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
IR - Iran 3
KE - Kenya 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LT - Lituania 3
PY - Paraguay 3
RO - Romania 3
RS - Serbia 3
TH - Thailandia 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
EU - Europa 2
GE - Georgia 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
LU - Lussemburgo 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BJ - Benin 1
BW - Botswana 1
CD - Congo 1
GH - Ghana 1
GT - Guatemala 1
KH - Cambogia 1
LV - Lettonia 1
ML - Mali 1
MM - Myanmar 1
Totale 10.771
Città #
Ashburn 614
Singapore 501
Hong Kong 475
Woodbridge 394
Santa Clara 385
Dallas 383
Fairfield 345
San Jose 338
Houston 302
Chandler 274
Ann Arbor 252
Shanghai 193
Seattle 162
Munich 159
Sofia 154
Serra 148
New York 135
Wilmington 135
Cambridge 131
Beijing 124
Milan 103
Boardman 85
Princeton 83
Los Angeles 81
Lawrence 67
Helsinki 63
Lauterbourg 63
Ho Chi Minh City 61
Florence 60
Medford 57
Pisa 48
Abidjan 46
Hanoi 46
Dearborn 42
São Paulo 41
Tokyo 41
Council Bluffs 40
Buffalo 37
Ottawa 37
London 36
Des Moines 35
Frankfurt am Main 34
Izmir 34
Dong Ket 32
Chicago 30
Istanbul 29
Hefei 26
Redondo Beach 26
Rome 25
Vienna 25
Nanjing 23
San Diego 20
Düsseldorf 18
Lagos 18
Seoul 16
Turku 15
Jacksonville 14
Ogden 14
Orem 13
San Francisco 13
Dakar 12
Fuzhou 12
Guangzhou 12
Lucca 12
Nuremberg 12
Lancaster 11
Denver 10
Jiaxing 10
Mexico City 10
Redwood City 10
Shenyang 10
Toronto 10
Warsaw 10
Wuhan 10
Brussels 9
Johannesburg 9
Phoenix 9
Poplar 9
Beauharnois 8
Brooklyn 8
Chennai 8
Mcallen 8
Montreal 8
Nanchang 8
Paris 8
Quito 8
Turin 8
Baku 7
Cascina 7
Changsha 7
Charlotte 7
Curitiba 7
Dhaka 7
Indiana 7
Naples 7
Norwalk 7
Quanzhou 7
Stockholm 7
Zurich 7
Atlanta 6
Totale 7.550
Nome #
Influence of depression and anxiety on circulating endothelial progenitor cells in patients with acute coronary syndromes 308
Role of circulating endothelial progenitor cells in the reparative mechanisms of stable ischemic myocardium 248
Arterial hypertension and atrial fibrillation: standard and advanced echocardiography from diagnosis to prognostication 228
Obstructive coronary atherosclerosis and ischemic heart disease: An elusive link! 220
Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update 216
Circulating endothelial progenitor cells are actively involved in the reparative mechanisms of stable ischemic myocardium 209
Influence of depression and anxiety on circulating endothelial progenitor cells in patients with acute coronary syndromes 202
Trimetazidine 198
Pharmacological approaches to coronary microvascular dysfunction 190
Prognostic value of cardiac power output to left ventricular mass in patients with left ventricular dysfunction and dobutamine stress echo negative by wall motion criteria 189
Determination of volatile organic compounds in human breath for monitoring heart failure patients 188
Resting heart rate is an independent predictor of left ventricular diastolic dysfunction in obese patients with or without arterial hypertension 186
Stress Testing After Complete and Successful Coronary Revascularization 185
Feasibility and functional correlates of left atrial volume changes during stress echocardiography in chronic coronary syndromes 176
Endothelial progenitor cells: An appraisal of relevant data from bench to bedside 173
Myocardial protection during PCI in STEMI : strategy reperfusion effects in acute MI patients (stream study) 169
Organization and Activity of Italian Echocardiographic Laboratories: A Survey of the Italian Society of Echocardiography and Cardiovascular Imaging 164
Trimetazidine and Other Metabolic Modifiers 164
Lung Ultrasound and Pulmonary Congestion During Stress Echocardiography 163
Appropriateness of use criteria in echocardiography: an Italian experience 160
The second law of thermodynamics and the heart 155
Ultrasound assessment of left ventricular force-frequency relationship to risk stratify patients with advanced chronic systolic heart failure 154
Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response : a pooled analysis of over 21,000 subjects from 27 clinical trials 153
Safety profile of statins alone or combined with ezetimibe : a pooled analysis of 27 studies including over 22,000 patients treated for 6-24 weeks 152
Pre-PCI angina post-PCI ischaemia: tales of ordinary madness 151
Sex-related differences in chronic heart failure 150
Reply letter to Dr. Xu et al. on role of circulating endothelial progenitor cells in the reparative mechanisms of stable ischemic myocardium 150
The central role of invasive functional coronary assessment for patients with ischemic heart disease 146
Trials in ischemic heart disease do not represent the ischemic universe 145
Antianginal Therapy for Stable Ischemic Heart Disease 143
Prediction of post percutaneous coronary intervention myocardial ischaemia 141
Interventional cardiology : Cost-effectiveness of PCI guided by fractional flow reserve 138
Postconditioning 136
A narrative overview: Have clinical trials of PCI vs medical therapy addressed the right question? 135
Prognostic value of stress echocardiography assessed by the ABCDE protocol 135
Do clinical trials in ischemic heart disease meet the needs of those with ischemia? 132
Hemodynamic heterogeneity of reduced cardiac reserve unmasked by volumetric exercise echocardiography 131
Perspectives in noninvasive imaging for chronic coronary syndromes 129
Higher 30-day readmission rate for suspicion of ACS : effect of kidney function 129
Controversies in fractional flow reserve 128
Feasibility and value of two-dimensional volumetric stress echocardiography 128
Interactions between coronary stenoses and microcirculation 126
Reshaping of italian echocardiographic laboratories activities during the second wave of covid-19 pandemic and expectations for the post-pandemic era 124
Myocardial ischemia: From disease to syndrome 121
Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging 120
The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction 119
Pancreatitis-associated Myocarditis: Systematic Review and Meta-analysis of a Deadly Duo 114
Resistant hypertension: an overview 113
The Role of Nitrates in the Management of Stable Ischemic Heart Disease: A Review of the Current Evidence and Guidelines 112
The ESC ACCA EAPCI EORP acute coronary syndrome ST-elevation myocardial infarction registry 111
Echocardiographic assessment of coronary microvascular dysfunction: Basic concepts, technical aspects, and clinical settings 110
Left atrial volume changes during exercise stress echocardiography in heart failure and hypertrophic cardiomyopathy 110
SAFETY OF NOVEL ORAL ANTICOAGULANTS COMPARED TO VITAMIN K ANTAGONISTS IN THE TREATMENT OF VENOUS THROMBOEMBOLISM: A SYSTEMATIC REVIEW AND META-ANALYSIS 109
Long-term follow-up of elective chronic total coronary occlusion angioplasty: Analysis from the U.K. central cardiac audit database 109
Myocardial ischemia as a multifactorial: Disease: What is new? 107
Casual diagnosis of abdominal aorta aneurysm during transthoracic echocardiographic test: Clinical case and literature review 106
Role of RAAS inhibition in preventing left ventricular remodeling in patients post myocardial infarction 104
The new clinical standard of integrated quadruple stress echocardiography with ABCD protocol 104
null 102
Radiation Exposure is Incresead Through the Last Ten Years 101
Efforts to decrase the door to balloon time might increase the incidence of unnecessary emergency cardiac catheterization and delay appropriate care 98
Sex-related differences in ventricular remodeling after myocardial infarction 98
Therapy against ischemic injury 96
Bleeding risk score: limits and practicability 95
Diagnostic approach for coronary microvascular dysfunction in patients with chest pain and no obstructive coronary artery disease 94
Ivabradine in Cardiovascular Disease Management Revisited: a Review 94
null 93
Microvascular function/dysfunction downstream a coronary stenosis 92
Pulmonary Congestion During Exercise Stress Echocardiography in Ischemic and Heart Failure Patients 90
null 89
Myocardial infarction with nonobstructive coronary arteries: from pathophysiology to therapeutic strategies 85
Mortality Prediction of the CHA2DS2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation 79
Trials in ischemic heart disease do not represent the ishemic universe 78
Acute pulmonary embolism: Focus on the clinical picture 77
null 75
Integrated quadruple stress echocardiography 75
HIT initiative: Discussion with the seniors 69
Right ventricular dysfunction is associated with chronic kidney disease and predicts survival in patients with chronic systolic heart failure. 66
Clinical outcomes of patients with coronary microvascular dysfunction in absence of obstructive coronary atherosclerosis 64
null 64
In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways 63
Persistent angina: the Araba Phoenix of cardiology 62
Myocardial 123I-metaiodobenzylguanidine imaging in hypertension and left ventricular hypertrophy 57
Long-Term Symptoms and Mortality in Takotsubo Syndrome Versus Acute Coronary Syndromes: A Matched Comparative Study 26
Exercise pulmonary hypertension in chronic thromboembolic pulmonary disease without resting pulmonary hypertension: A systematic review and meta-analysis 21
Myocardial infarction with non-obstructive coronary arteries: a pathway to achieve guideline adherence 19
Myocardial infarction with nonobstructive coronary arteries - the European PERspective (SNIPER) survey 18
Totale 10.956
Categoria #
all - tutte 33.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.615


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202179 0 0 0 0 0 0 0 0 0 0 0 79
2021/2022767 8 22 22 38 142 109 34 25 46 34 64 223
2022/20231.001 163 161 84 33 111 113 7 84 156 7 55 27
2023/2024697 44 67 77 43 87 153 26 36 13 22 37 92
2024/20252.625 22 85 42 136 262 311 279 118 326 336 233 475
2025/20263.171 233 332 453 321 361 238 414 146 184 260 110 119
Totale 10.956